Publication | Open Access
A Pooled Analysis of Two Phase 3 Clinical Trials of Dalfampridine in Patients with Multiple Sclerosis
29
Citations
24
References
2014
Year
D-ER demonstrated efficacy for the improvement of walking in patients with MS; response was independent of demographic and clinical characteristics.
| Year | Citations | |
|---|---|---|
Page 1
Page 1